Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 25,926 shares at $50.41 ($1.3M) on 2017-04-12, disclosed to the SEC on 2017-04-13.
Open-market sale of $1.3M NBIX by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.41 | 12,861 | $648K | 49.6% |
| 2 | $50.41 | 12,861 | $648K | 49.6% |
| 3 | $51.23 | 204 | $10K | 0.8% |
| Total | $50.42 avg | 25,926 | $1.3M | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |